acetylcysteine
AssetSmall moleculeAlso AR10, Acetadote EF, NAC, N-acetylcysteine
Glutathione precursor and mucolytic agent with antioxidant properties.
- Stage
- Approved
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- Indications
- 9
- Trials
- 288
- Developers
- 4
Indications
10No named disease
Approvedaccessdata.fda.gov7 Oct 2026
Abnormal mucus secretion
Phase 3COMPLETEDNCT03843541clinicaltrials.gov7 Oct 2026
Acetaminophen overdose
Phase 3TERMINATEDNCT01118663clinicaltrials.gov7 Oct 2026
7 more
- Targets and what it contains1
- Owner and partners4
- Trials288
- Evidence for its targets2
- Competitors2
- Aging relevance1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 14 sources